Igor Uppal

Bachelor of Medicine and Bachelor of Science,  Massachusetts General Hospital 

Location: Germany

Consulting Services

IT-Web-Mobile Technology Data Science-Bioinformatics Admin and Customer Support Grant Submission Career Advice and Mentoring

Areas Of Interest

Orchid Fresh II Cordis, Ectopia Ulnar Nerve Entrapment Protein, SecA Self-Regulation, Emotion Lymphocytic Leukemia, Chronic, B Cell Receptors, CKR5 Spasm, Esophageal Cytophagaceae Superior Segmental Optic Hypoplasia Septal Occluder, CardioSeal Prisoners Immunoglobulin A Seastar Torsion Fractures Elevators and Escalators Vicarious Trauma Duddingtonia Cotransporter, Pit1 Sodium-Phosphate Endocannabinoids Infectious Disease Transmission, Professional-to-Patient Monocyte-Macrophage Precursor Cell Gene Dosages Epilepsy, Myoclonus Congenital Dyserythropoietic Anemia, Type I Tumors of the Nervous System Benzhydramine Sepsis Associated Delirium Giant Cell Fibroblastoma Sensory Neuritides Polymorphic Reticuloses

Professional Narrative

Dr. Igor Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Amgen 2009
Senior Director, Harvard Med 2016

Education

Director Medicine, Yale School of Medicine 1988
Bachelor of science in nursing, Perelman School of Medicine 2019

Referees


Publications

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :